Effectiveness of GV20-based wearable low-level laser acupoint therapy for pain on head.

Researchers investigated whether a wearable low-level laser device targeting specific acupuncture points on the head could reduce headache pain. This study focused on temporal headaches—pain on the side of the head—using a modern technological approach to traditional acupuncture principles.

The study involved 48 participants who were randomly assigned to receive either real laser treatment or a sham (placebo) treatment. Neither the participants, researchers, nor assessors knew who received which treatment, making this a rigorous scientific design. The real treatment group wore a device that delivered low-level laser therapy to five specific points on the top of the head: Baihui (GV20) and four surrounding points called Sishencong (EX-HN1). The laser used was 650 nanometers wavelength at 5 milliwatts power for 30 minutes per session, delivering approximately 9 joules of energy to each point.

Researchers measured pain using two methods: a standard 0-10 pain scale (Visual Analog Scale) and a pressure pain test using a 300-gram monofilament on the right temple area. Participants in the laser treatment group experienced significantly greater pain reduction compared to those receiving sham treatment.

This research suggests that wearable laser acupoint therapy may offer an effective, non-invasive option for people suffering from temporal headaches. The technology combines traditional acupuncture point location with modern laser therapy, potentially providing pain relief without needles. The wearable nature of the device could make treatment more convenient and accessible for patients seeking drug-free headache management. If you're considering acupuncture or related therapies for headache pain, consult with a licensed acupuncturist or qualified healthcare provider to determine the most appropriate treatment approach for your condition.

This triple-blinded, randomized controlled trial (n=48) evaluated wearable low-level laser acupoint therapy (LLLAT) for temporal headache. Participants were randomized to active treatment (n=24) or sham control (n=24). The intervention delivered 650nm wavelength laser at 5mW for 30 minutes to GV20 (Baihui) and bilateral EX-HN1 (Sishencong) points simultaneously, providing approximately 9 joules per acupoint. Outcome measures included Visual Analog Scale (VAS 0-10) scores and deep pressure pain assessment using 300g monofilament on the right temporal region. The active LLLAT group demonstrated statistically significant reduction in mean VAS pain scores compared to sham treatment. Clinical implications suggest that concurrent application of low-level laser therapy to GV20 with surrounding EX-HN1 points using specified parameters (650nm, 5mW, 30 minutes) represents an effective non-invasive modality for temporal headache management. The wearable delivery system offers practical advantages for clinical application, potentially expanding treatment accessibility while maintaining therapeutic efficacy consistent with traditional acupoint selection principles.